Readmission Reduction Interventions for Sepsis or Pneumonia
(ACCOMPLISH Trial)
Trial Summary
What is the purpose of this trial?
An adaptive platform trial to compare effectiveness of different care models to prevent readmissions for patients hospitalized with sepsis or lower respiratory tract infection. The primary outcome is number of days spent at home within 90 days after hospital discharge.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the idea that Readmission Reduction Interventions for Sepsis or Pneumonia is an effective treatment?
The available research shows that Rapid Response Teams (RRTs), which are part of Readmission Reduction Interventions, help in detecting and responding to patients whose health is getting worse. Although the studies don't directly measure the effectiveness of these interventions for sepsis or pneumonia, they suggest that RRTs can improve patient care by responding quickly to health declines. This implies that such interventions could be beneficial for conditions like sepsis or pneumonia, where quick response is crucial.12345
What safety data exists for readmission reduction interventions for sepsis or pneumonia?
The provided research primarily discusses Rapid Response Teams (RRTs) in hospital settings, focusing on their activation, outcomes, and organizational structures. However, it does not directly address safety data for interventions like Enhanced Response Team, Remote Patient Monitoring, or Structured Telephone Support specifically for sepsis or pneumonia readmission reduction. The studies highlight the role of RRTs in managing critically ill patients and improving outcomes, but specific safety data for the mentioned interventions is not detailed in these abstracts.678910
Is the treatment in the trial 'Readmission Reduction Interventions for Sepsis or Pneumonia' promising?
Yes, the treatment is promising. Remote patient monitoring (RPM) has shown potential in reducing hospital readmissions and improving patient satisfaction by allowing patients to be monitored at home. This approach can help hospitals manage resources better and provide quality care, especially in challenging times.1112131415
Research Team
Kalpana Char, MD
Principal Investigator
UPMC Health Plan
Sachin Yende, MD
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This trial is for adults over 21 who were hospitalized with sepsis or a lower respiratory infection, have a moderate to high risk of readmission, and are going home or to certain facilities. They must be Medicare enrollees or UPMC Health Plan members. Excluded are those with no PCP approval for RPM, pregnant women, long-term skilled nursing facility residents, lacking technology for RPM participation, severe cognitive issues without a proxy, hospice patients, and current participants in similar programs.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive structured telephone support or remote patient monitoring for up to 90 days post-discharge
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Enhanced Response Team
- High-intensity Remote Patient Monitoring (RPM-High)
- Low-intensity Remote Patient Monitoring (RPM-Low)
- Standard Response Team
- Structured Telephone Support (STS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator